Amy B Knudsen

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. pmc Rescreening of persons with a negative colonoscopy result: results from a microsimulation model
    Amy B Knudsen
    Institute for Technology Assessment, Massachusetts General Hospital, 101 Merrimac Street, 10th Floor, Boston, MA 02114, USA
    Ann Intern Med 157:611-20. 2012
  2. pmc Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population
    Amy B Knudsen
    Institute for Technology Assessment, Massachusetts General Hospital, 101 Merrimac St, 10th Floor, Boston, MA 02114
    J Natl Cancer Inst 102:1238-52. 2010
  3. pmc Cost-Savings to Medicare From Pre-Medicare Colorectal Cancer Screening
    Simon L Goede
    Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands Division of Health Policy and Management, University of Minnesota, Minneapolis, MN Department of Radiology, Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA Department of Health Policy and Management, Emory University, Atlanta, GA Coverage and Analysis Group, Centers for Medicare and Medicaid Services, Baltimore, MD Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
    Med Care 53:630-8. 2015
  4. pmc Secular trends in colon and rectal cancer relative survival
    Carolyn M Rutter
    Affiliations of authors Group Health Research Institute, Seattle, WA CMR, EAJ Division of Cancer Control and Population Sciences National Cancer Institute, Bethesda, MD EJF Institute for Technology Assessment, Department of Radiology, Massachusetts General Hospital, Boston MA ABK Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis MN KMK Division of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA DS
    J Natl Cancer Inst 105:1806-13. 2013
  5. pmc Calibration methods used in cancer simulation models and suggested reporting guidelines
    Natasha K Stout
    Department of Ambulatory Care and Prevention, Harvard Medical School Harvard Pilgrim Health Care, Boston, Massachusetts 02215, USA
    Pharmacoeconomics 27:533-45. 2009
  6. pmc Cost-effectiveness of prophylactic surgery for duodenal cancer in familial adenomatous polyposis
    Wesley H Greenblatt
    Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts, USA
    Cancer Epidemiol Biomarkers Prev 18:2677-84. 2009
  7. ncbi request reprint Use of modeling to evaluate the cost-effectiveness of cancer screening programs
    Amy B Knudsen
    Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA
    J Clin Oncol 25:203-8. 2007

Collaborators

Detail Information

Publications7

  1. pmc Rescreening of persons with a negative colonoscopy result: results from a microsimulation model
    Amy B Knudsen
    Institute for Technology Assessment, Massachusetts General Hospital, 101 Merrimac Street, 10th Floor, Boston, MA 02114, USA
    Ann Intern Med 157:611-20. 2012
    ..Persons with a negative result on screening colonoscopy are recommended to repeat the procedure in 10 years...
  2. pmc Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population
    Amy B Knudsen
    Institute for Technology Assessment, Massachusetts General Hospital, 101 Merrimac St, 10th Floor, Boston, MA 02114
    J Natl Cancer Inst 102:1238-52. 2010
    ....
  3. pmc Cost-Savings to Medicare From Pre-Medicare Colorectal Cancer Screening
    Simon L Goede
    Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands Division of Health Policy and Management, University of Minnesota, Minneapolis, MN Department of Radiology, Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA Department of Health Policy and Management, Emory University, Atlanta, GA Coverage and Analysis Group, Centers for Medicare and Medicaid Services, Baltimore, MD Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
    Med Care 53:630-8. 2015
    ..We aimed to estimate the long-term implications of increased CRC screening in the pre-Medicare population (50-64 y) on costs in the pre-Medicare and Medicare populations (65+ y)...
  4. pmc Secular trends in colon and rectal cancer relative survival
    Carolyn M Rutter
    Affiliations of authors Group Health Research Institute, Seattle, WA CMR, EAJ Division of Cancer Control and Population Sciences National Cancer Institute, Bethesda, MD EJF Institute for Technology Assessment, Department of Radiology, Massachusetts General Hospital, Boston MA ABK Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis MN KMK Division of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA DS
    J Natl Cancer Inst 105:1806-13. 2013
    ..Relative survival is a metric that accounts for these concurrent changes, allowing assessment of changes in CRC survival. We describe stage- and location-specific trends in relative survival after CRC diagnosis...
  5. pmc Calibration methods used in cancer simulation models and suggested reporting guidelines
    Natasha K Stout
    Department of Ambulatory Care and Prevention, Harvard Medical School Harvard Pilgrim Health Care, Boston, Massachusetts 02215, USA
    Pharmacoeconomics 27:533-45. 2009
    ..To aid peer-review and facilitate discussion of modelling methods, we propose a standardized Calibration Reporting Checklist for model documentation...
  6. pmc Cost-effectiveness of prophylactic surgery for duodenal cancer in familial adenomatous polyposis
    Wesley H Greenblatt
    Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts, USA
    Cancer Epidemiol Biomarkers Prev 18:2677-84. 2009
    ..Because no clinical trials have assessed this recommendation, a modeling approach was used to evaluate the cost-effectiveness of various treatment strategies...
  7. ncbi request reprint Use of modeling to evaluate the cost-effectiveness of cancer screening programs
    Amy B Knudsen
    Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA
    J Clin Oncol 25:203-8. 2007
    ..Finally, we offer some suggestions for important concepts to consider when interpreting model results...